Innovating Cardiac Diagnostics: Engineers4Medicine Debuts at GITEX 2025, Making Waves in Global Healthtech Arena

Polish medtech startup Engineers4Medicine brings its AI-based Mudisocard system to Dubai’s GITEX Global 2025, aiming to reshape cardiac care through early detection and streamlined diagnostics.

Introduction

In the heart of Dubai, where the world’s leading technology players gather each year, GITEX Global 2025 stands as more than a trade show — it is a crucible of innovation, investment, and impact. This year, among the thousands of exhibitors, the Polish startup Engineers4Medicine (EFM) is making its mark, unveiling its Mudisocard diagnostic platform to healthcare professionals, investors, and tech enthusiasts. Their presence signals not only ambition, but a commitment to reimagining how cardiac conditions are diagnosed and managed globally.

About GITEX Global 2025

GITEX Global 2025, now in its 45th edition, is widely regarded as the world’s largest tech and AI convergence, spanning from October 13 to 17 in Dubai. This year’s edition is historic: it marks the final time the event will be held at its longtime venue, the Dubai World Trade Centre, as organizers prepare to relocate to Expo City in 2026. GITEX 2025 spans over 40 exhibition halls with dual venues (DWTC and Dubai Harbour), hosting over 6,500 exhibitors, 1,200 investors, and 1,800 startups from more than 180 countries.

At its core, GITEX convenes the leading voices in AI, healthtech, biotechnology, robotics, quantum computing, and sustainable infrastructure. It is also the hub for the startup showcase Expand North Star, connecting nimble disruptors with global capital and strategic partners.

This year’s themes include AI-driven healthcare, data privacy, biotech convergence, digital governance, and smart mobility — as seen in GITEX’s dramatic unveilings, such as AI-patrol vehicles and next-generation “trackless trams” as part of Dubai’s smart city agenda.

About the Client: Engineers4Medicine (EFM)

Headquartered in Białystok, Poland, Engineers4Medicine (EFM R&D S.A.) is a medtech startup focused on developing advanced diagnostic solutions for cardiovascular disease. Their mission is clear: “to improve patients’ care by facilitating new standards in medical service through implementing more powerful tools to support healthcare professionals in their work.”

Central to EFM’s offering is their Mudisocard platform — an AI-powered diagnostic system that analyzes electrical and mechanical dynamics of the heart to detect subtle deviations. Unlike conventional diagnostics that rely on multiple tests over days or weeks, Mudisocard aims to deliver actionable insights in a single visit, helping clinicians distinguish chronic heart failure from conditions like chronic obstructive pulmonary disease.

In 2023–2024, EFM reached several milestones: they developed a working prototype, applied for patents across the EU, the U.S., UAE, Saudi Arabia, and South Korea, and obtained ISO 13485 certification (quality management for medical devices) from TÜV NORD Polska. Through these steps, EFM is positioning Mudisocard for commercialization and regulatory approval across diverse geographies.

EFM’s Participation at GITEX 2025

At GITEX 2025, Engineers4Medicine is exhibiting within the healthtech / biotech clusters, using the global stage to introduce Mudisocard to a broad audience of decision-makers: hospital administrators, health ministries, biotech investors, and digital health strategists. While detailed booth location information remains proprietary, EFM’s selection to be part of this elite global event itself speaks volumes about the maturity and promise of their technology.

Beyond showcasing the technology, EFM is active in networking sessions, pitch …